Related Experiment Videos
The efficacy of dietary therapy for phenylketonuria
Insights
Early diagnosis and treatment of phenylketonuria (PKU) with a low-phenylalanine diet significantly improves intellectual outcomes. Newborn screening programs are crucial for identifying PKU early and ensuring better cognitive development.
Area of Science:
- Metabolic Disorders
- Genetics
- Pediatric Neurology
Background:
- Phenylketonuria (PKU) is a rare genetic disorder.
- Untreated PKU can lead to severe intellectual disability and neurological damage.
- Early intervention is critical for managing PKU and preventing long-term complications.
Purpose of the Study:
- To evaluate the long-term intellectual outcomes of patients with classical phenylketonuria.
- To assess the impact of early diagnosis and low-phenylalanine diet on cognitive development.
- To investigate the effects of dietary treatment on electroencephalogram (EEG) abnormalities and anticonvulsant medication needs.
Main Methods:
- Retrospective review of 94 patients with classical phenylketonuria.
- Analysis of intellectual quotient (IQ) scores in relation to age at diagnosis and treatment initiation.
- Assessment of EEG findings and anticonvulsant medication status before and after dietary intervention.
Main Results:
- Early treatment (before 2 months) with a low-phenylalanine diet led to normal or near-normal IQ in 27 of 38 patients.
- Abnormal EEGs normalized in 21 of 28 patients after dietary initiation.
- Nine of 12 patients on anticonvulsants were able to discontinue medication following dietary treatment.
- Sibling pair comparisons showed significantly better IQ in early-treated individuals.
Conclusions:
- Early diagnosis through newborn screening and prompt initiation of a low-phenylalanine diet are essential for optimal cognitive outcomes in PKU.
- Dietary management effectively normalizes EEG abnormalities and reduces the need for anticonvulsant medication.
- Centralization of PKU diagnosis and treatment is recommended to ensure consistent and high-quality care.
Abstract:
Ninety-four patients with classical phenylketonuria are reviewed. Early treatment with a low phenylalanine diet usually results in normal or near-normal I.Q. Twenty-seven of the 38 patients diagnosed before 2 months of age have an I.Q. in the normal range. Of the other 11, six are dull normal, four are borderline and one is frankly retarded. Adequate reasons are given for the less than optimal results in these 11 early-treated patients. Twenty-one of the 28 patients presenting with abnormal electroencephalograms showed normal tracings soon after initiation of diet and four of the other seven improved. Nine of 12 on continuous anticonvulsant medication at the time of presentation were able to discontinue this soon after institution of dietary measures. Eighteen of the 19 sibling pair comparisons revealed a better ultimate I.Q. in the early-treated sib. A plea for early diagnosis by continuation of newborn screening programs and for centralization of diagnostic confirmation and treatment is made.